Table 1.
Name | Method | advantage | Disadvantage |
---|---|---|---|
HOMA-IR | (Plasma insulin during fasting × plasma glucose during fasting)/22.5 | Simple, minimally invasive, predicts fasting steady-state glucose and insulin levels | limitations because of significant heterogeneity of cut-off value and IR definitions; HOMA-IR may not be appropriate in patients with severely impaired or absent β-cell function |
OGTT | After the overnight fast, fasting blood glucose levels were measured and then remeasured at the time point after drinking 75 g of glucose solution. | Simple, minimally invasive | Relatively crude measurement of glucose tolerance without measuring insulin sensitivity and insulin secretion components |
C-peptide release test | After the overnight fast, fasting blood C-peptide levels were measured and then remeasured at the time point after drinking 75 g of glucose solution. | Simple, minimally invasive; Long half-life; It is not interfered with by insulin antibodies and can more accurately reflect the patient’s β-cell function. | Relatively crude; Needs to be analyzed in conjunction with blood glucose and insulin |
TyG index | Fasting triglyceride [mg/dL] × fasting glucose [mg/dL]/2 | Simple, minimally invasive; Suitable for clinical and epidemiological studies | limitations because of significant heterogeneity of cut-off value and IR definitions |
HOMA-IR, Homeostasis model assessment of IR; OGTT, oral glucose tolerance tests; TyG index, triglyceride glucose index. IR, insulin resistance.